Watching foam treatment for cysts in autosomal polycystic disease
Part of Genetic & congenital, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study follows adults with inherited kidney and/or liver cysts that are causing symptoms to see how a foam sclerotherapy procedure may help and what outcomes happen over about a year. You may be eligible if you have a few sizable, specific-type cysts and can safely attend follow-up visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must have a clinical diagnosis of ADPKD or ADPLD
- You need 1 to 3 main cysts on the kidney or liver that are not growing outward (non-exophytic)
- Your biggest cyst must be large enough to matter (at least 4 cm in all three dimensions or at least 400 cc by size)
- Your cysts should be causing “pressure-type” symptoms (compressive symptoms)
- You must be able and willing to follow up for about 12 months (12 ± 1 months) and give consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people with autosomal dominant polycystic kidney disease to learn more about the condition. It is an observational study, meaning no new treatments are tested—just gathering information from your medical history and tests.
This study looks at how the body’s “Nrf2 response” works in people with autosomal dominant polycystic kidney disease (ADPKD). It may help researchers better understand disease biology and future treatments by comparing kidney-related signals in ADPKD patients and healthy volunteers.
This study collects medical information and samples from patients with podocytopathy—a type of autoimmune kidney disease that causes protein leakage into urine. Researchers will analyze your medical records and any blood or kidney tissue samples you've already had to better understand the disease and find better treatments.
This study enrolls adults with autosomal dominant polycystic kidney disease (ADPKD) to better understand the disease and its related changes in the body. It may help researchers find improved ways to track the condition and support future treatments.
This study enrolls people who have been diagnosed with autosomal dominant polycystic kidney disease (ADPKD), a genetic kidney condition that can cause kidney cysts. It aims to learn about this specific form of the disease so better care is possible for the right patients.
This observational study follows people early in autosomal dominant polycystic kidney disease (ADPKD) and also some healthy volunteers to learn how the kidneys work over time. It may help researchers understand early changes, which could guide future treatments.
Hear when a new Autosomal Dominant Polycystic Kidney trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.